Arkansas Progressive Medicine in Jonesboro has launched a new therapy targeting adults with treatment-resistant depression. This innovative approach offers a non-invasive, drug-free alternative to conventional antidepressant medications.
The treatment, known as EXOMIND™, utilizes an FDA-cleared device designed specifically for adults diagnosed with Major Depressive Disorder who have not responded adequately to traditional medications. EXOMIND™ employs patented Exo™TMS technology to stimulate specific brain regions that regulate emotions, cognition, and self-control.
Dr. Flippin from Arkansas Progressive Medicine emphasized that this therapy is not limited to those with severe mental illness. “This is about nurturing mental health and managing daily stressors,” he stated.
Statistics from the National Institute of Mental Health highlight the growing prevalence of mental health issues, with over 20% of U.S. adults experiencing some form of mental illness in 2019-2020. This figure rose to over 23% by 2022, indicating a pressing need for effective treatment options.
EXOMIND™ sessions are brief, lasting less than 30 minutes, and do not require sedation or recovery time. Patients report sensations similar to light tapping on their heads during treatment. Following each session, individuals can immediately return to their normal activities, making this therapy compatible with busy lifestyles.
The treatment is designed to fit seamlessly into patients’ weekly routines, typically administered once a week for six weeks. While the primary focus is on alleviating depression, the device may also address other behavioral issues, such as overeating and nicotine addiction.
Although the company has not disclosed data from extensive clinical trials, it positions EXOMIND™ as a supplementary option rather than a replacement for existing mental health treatments. “EXOMIND™ signifies a change in our approach to mental wellness,” Dr. Flippin explained, highlighting its role as a comfortable, drug-free strategy for managing mental health.
A patient testimonial shared by the clinic illustrates the therapy’s impact. A participant named Jennifer from Phoenix reported a return of “happiness” and “joy” after undergoing treatment. Such accounts underscore the potential of EXOMIND™ to improve quality of life for those struggling with depression.
Patients are encouraged to consult with their healthcare providers before starting treatment to ensure it aligns with their specific needs. For more information or to schedule a consultation, interested individuals can visit arkansasprogressivemedicine.net or call (870) 520-6007.
